IRIS
VESPASIANI GENTILUCCI, UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.184
NA - Nord America 942
EU - Europa 507
OC - Oceania 23
AF - Africa 15
SA - Sud America 9
Totale 3.680
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.441
US - Stati Uniti d'America 920
CN - Cina 409
HK - Hong Kong 250
GB - Regno Unito 160
IT - Italia 157
DE - Germania 66
IN - India 36
NL - Olanda 30
CZ - Repubblica Ceca 28
AU - Australia 23
CA - Canada 19
TR - Turchia 17
FI - Finlandia 15
UA - Ucraina 15
FR - Francia 14
JP - Giappone 7
ZA - Sudafrica 7
BR - Brasile 4
ET - Etiopia 4
ID - Indonesia 4
PL - Polonia 4
SA - Arabia Saudita 4
CH - Svizzera 3
CL - Cile 3
IR - Iran 3
MA - Marocco 3
AT - Austria 2
BE - Belgio 2
KR - Corea 2
KZ - Kazakistan 2
PA - Panama 2
PH - Filippine 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
CY - Cipro 1
DK - Danimarca 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
Totale 3.680
Salva come PNG Salva come JPEG
Città #
Singapore 361
Ashburn 249
Hong Kong 241
Boardman 216
Hefei 197
London 145
Shanghai 134
Rome 70
Council Bluffs 36
Los Angeles 30
San Francisco 30
Seattle 29
Brno 28
Pune 26
West Jordan 22
Munich 18
Amsterdam 17
Toronto 17
Washington 16
Helsinki 15
Canberra 12
Santa Clara 12
Sona 11
New York 10
Guangzhou 8
Melbourne 7
Redmond 6
Tokyo 6
Milan 5
Paris 5
Central 4
Frankfurt am Main 4
Naples 4
Sydney 4
Warsaw 4
Zhengzhou 4
Addis Ababa 3
Bari 3
Bologna 3
Brownsville 3
Haikou 3
Kyiv 3
Rabat 3
Riyadh 3
Valsamoggia 3
Anderlecht 2
Andover 2
Berlin 2
Boydton 2
Cervignano del Friuli 2
Cinisello Balsamo 2
Delhi 2
Falls Church 2
Ferrara di Monte Baldo 2
Foligno 2
Handan 2
Hangzhou 2
Hanover 2
Houston 2
Kharkiv 2
Liverpool 2
Messina 2
Newark 2
Perugia 2
Rovereto 2
Shenzhen 2
Shijiazhuang 2
Suzhou 2
São Paulo 2
Tianjin 2
Torino 2
Vienna 2
Xingtai 2
Zurich 2
Almere Stad 1
Basingstoke 1
Beijing 1
Bengaluru 1
Bratislava 1
Budapest 1
Buffalo 1
Campobasso 1
Changchun 1
Changsha 1
Changzhou 1
Charlotte 1
Chengdu 1
Chicago 1
Chisinau 1
Ciampino 1
Cleveland 1
Cold Lake 1
Des Plaines 1
Dhaka 1
Dongguan 1
Dublin 1
Fairport 1
Freetown 1
Fuzhou 1
Gauteng 1
Totale 2.114
Salva come PNG Salva come JPEG
Nome #
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 41
GH-resistance in different stages of chronic liver disease 41
Advances in management of periprosthetic joint infections: an historical prospective study 39
Diabetes in chronic liver disease: from old concepts to new evidence 39
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 38
Factors enhancing treatment of hepatitis C virus⇓infected italian people who use drugs: The CLEO-GRECAS experience 38
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 38
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 37
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 37
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 37
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 36
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 36
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 36
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 35
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 35
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 35
[A 73-year-old woman with vomiting and metabolic alkalosis] 35
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 34
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 34
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 34
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 33
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 33
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 33
[A 61-year-old woman with abdominal pain and urination disorders] 32
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 32
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 31
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 31
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 31
AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement 30
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 29
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 29
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 29
Assessment of liver function by the exhaled breath-print during chronic liver disease 29
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 29
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 29
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 29
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 29
TNF-alpha and growth hormone resistance in patients with chronic liver disease 28
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 28
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 28
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 28
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 28
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 28
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 28
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 28
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 28
A challenging alfa-fetoprotein in a cirrhotic patient 27
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 27
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 27
Liver involvement in the course of thymoma-associated multiorgan autoimmunity: The first histological description 27
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 26
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 26
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 26
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 26
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 25
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 25
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 25
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 25
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 24
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 24
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 24
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 24
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 23
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 23
The pharmacological treatment of chronic comorbidities in COPD: mind the gap! 22
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 22
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 22
Reply 21
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. 21
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 21
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 20
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 20
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 20
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 20
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 20
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 20
Raised C-reactive protein levels in patients with recent onset type 1 diabetes 20
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 20
Hepatic complications of bariatric surgery : the reverse side of the coin 19
Effect of sibutramine on plasma C-reactive protein, leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials 19
The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen 19
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 19
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 18
Westernization of the Filipino population resident in Rome: obesity, diabetes and hypertension 18
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b 18
Tubercolomi cerebrali multipli resistenti alla terapia convenzionale in un soggetto immunosoppresso [Multiple cerebral tuberculomas resistant to conventional therapy in an immunocompromised subject] 18
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma 18
Boosting pigment epithelial-derived factor: a promising approach for the treatment of early portal hypertension 18
The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period 18
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 17
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy 17
SINDROME DI SJÖGREN (SS) ASSOCIATA A MALATTIA INFIAMMATORIA PELVICA (PID): DESCRIZIONE DI UN CASO CLINICO 17
Lipophagy Impairment Is Associated With Disease Progression in NAFLD 17
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 17
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 16
The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention 16
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 16
Uomo di 67 anni con dolore addominale, anoressia, febbricola [67 year old man with abdominal pain, anorexia and low-grade fever] 16
Reelin expression in human liver of patients with chronic hepatitis C infection 16
Pain and Frailty in Hospitalized Older Adults 16
Totale 2.631
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.969
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022336 0 2 8 0 3 3 2 6 46 4 4 258
2022/2023112 12 1 6 4 10 2 30 4 3 5 33 2
2023/2024636 26 50 18 62 61 269 2 37 8 40 20 43
2024/20252.671 131 57 236 45 110 186 143 34 482 562 685 0
Totale 3.755